%20--%3e%3csvg%20width='512'%20height='512'%20viewBox='0%200%20135.46666%20135.46667'%20version='1.1'%20id='svg185'%20sodipodi:docname='wserie.svg'%20inkscape:version='1.2.2%20(b0a8486541,%202022-12-01)'%20inkscape:export-filename='../../public/wserie.png'%20inkscape:export-xdpi='96'%20inkscape:export-ydpi='96'%20xmlns:inkscape='http://www.inkscape.org/namespaces/inkscape'%20xmlns:sodipodi='http://sodipodi.sourceforge.net/DTD/sodipodi-0.dtd'%20xmlns:xlink='http://www.w3.org/1999/xlink'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:svg='http://www.w3.org/2000/svg'%3e%3csodipodi:namedview%20id='namedview187'%20pagecolor='%23ffffff'%20bordercolor='%23666666'%20borderopacity='1.0'%20inkscape:showpageshadow='2'%20inkscape:pageopacity='0.0'%20inkscape:pagecheckerboard='0'%20inkscape:deskcolor='%23d1d1d1'%20inkscape:document-units='mm'%20showgrid='false'%20inkscape:zoom='0.75187991'%20inkscape:cx='-219.44994'%20inkscape:cy='212.79994'%20inkscape:window-width='1920'%20inkscape:window-height='1029'%20inkscape:window-x='0'%20inkscape:window-y='27'%20inkscape:window-maximized='1'%20inkscape:current-layer='layer1'%20/%3e%3cdefs%20id='defs182'%3e%3cradialGradient%20inkscape:collect='always'%20xlink:href='%23linearGradient1249'%20id='radialGradient1251'%20cx='254'%20cy='95.249992'%20fx='254'%20fy='95.249992'%20r='67.65345'%20gradientUnits='userSpaceOnUse'%20/%3e%3clinearGradient%20inkscape:collect='always'%20id='linearGradient1249'%3e%3cstop%20style='stop-color:%2334b86b;stop-opacity:1;'%20offset='0'%20id='stop1245'%20/%3e%3cstop%20style='stop-color:%23206f43;stop-opacity:1;'%20offset='1'%20id='stop1247'%20/%3e%3c/linearGradient%3e%3clinearGradient%20inkscape:collect='always'%20xlink:href='%23linearGradient1271'%20id='linearGradient1273'%20x1='225.37227'%20y1='95.249992'%20x2='297.42328'%20y2='95.249992'%20gradientUnits='userSpaceOnUse'%20/%3e%3clinearGradient%20inkscape:collect='always'%20id='linearGradient1271'%3e%3cstop%20style='stop-color:%23ffffff;stop-opacity:1;'%20offset='0'%20id='stop1267'%20/%3e%3cstop%20style='stop-color:%23adadad;stop-opacity:1;'%20offset='1'%20id='stop1269'%20/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20inkscape:label='Layer%201'%20inkscape:groupmode='layer'%20id='layer1'%3e%3cg%20id='g1293'%20transform='translate(-186.26667,-27.516659)'%3e%3ccircle%20style='fill:url(%23radialGradient1251);fill-opacity:1;stroke:none;stroke-width:0.159763px;paint-order:fill%20markers%20stroke;stop-color:%23000000'%20id='path358'%20cx='254'%20cy='95.249992'%20r='67.65345'%20/%3e%3cpath%20id='path1748'%20style='fill:url(%23linearGradient1273);fill-opacity:1;stroke:none;stroke-width:0.127407px;paint-order:fill%20markers%20stroke;stop-color:%23000000'%20inkscape:transform-center-x='-12.008464'%20d='m%20225.37227,45.1744%20v%2032.19152%202.85227%20l%2031.87352,15.0318%20-31.87352,15.03181%20v%202.85226%2032.19153%20l%2072.05101,-33.97984%20-34.12905,-16.09576%2034.12905,-16.09576%20z'%20/%3e%3c/g%3e%3c/g%3e%3c/svg%3e){kind=small}
Part 2
Fatal Experiments: The Downfall of a Supersurgeon - S1 - E2
In the summer of 2012, supersurgeon Macchiarini is under pressure when problems start to arise. His pioneering transplant work seems at risk when he discovers faults with the new synthetic organs. Macchiarini still has faith in the procedure and plans new operations. This time it will no longer be fatally ill patients on whom he tries out his new methods, but patients whose condition is not life-threatening. Will Macchiarini succeed with his pioneering work?
Fatal Experiments: The Downfall of a Supersurgeon: Season 1 - 3 Episode s
1x1 - Part 1
January 13, 2016
Paolo Macchiarini is one of world's most famous surgeons. He hopes to revolutionize medicine by creating a new type of synthetic organ - a vision that could save many lives. But the Italian surgeon has also been accused of using terminally ill patients as human guinea pigs as well as falsifying his science. Is he a genius - or is he behind one of medicine's biggest scandals?
1x2 - Part 2
January 20, 2016
In the summer of 2012, supersurgeon Macchiarini is under pressure when problems start to arise. His pioneering transplant work seems at risk when he discovers faults with the new synthetic organs. Macchiarini still has faith in the procedure and plans new operations. This time it will no longer be fatally ill patients on whom he tries out his new methods, but patients whose condition is not life-threatening. Will Macchiarini succeed with his pioneering work?
1x3 - Part 3
January 27, 2016
By 2014, four Karolinska doctors started to question Macchiarini's transplantation of plastic tracheas and raised the alarm at Karolinska University Hospital and Karolinska Institute. They suspected that Macchiarini had been lying in his scientific papers and that patients' lives were being put at risk by a technique which had not been properly tested or investigated beforehand. But still his employer, the Karolinska Institute, defended him and claimed nothing was amiss.